Another recently discovered mechanism is represented by the production of IL-32 by MM cells, which, in turn, increased production by TAM of indoleamine 2,3-dioxygenase (IDO), a molecule with a well-known inhibitory effect on T cells [115]. This evidence concerns the gene IDO1 and Miyoshi myopathy.